id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2009-D-0137-0011,FDA,FDA-2009-D-0137,"Tab 27 - PubMed Results - ""Chagas Disease & The U. S. Blood Supply""  - Reference [re FDA-2009-D-0137-0002]",Supporting & Related Material,REF-Reference (internal unless indicated),2009-04-10T04:00:00Z,2009,4,,,2009-04-10T16:00:00Z,,0,0,090000648092ff9e
FDA-2009-D-0137-0009,FDA,FDA-2009-D-0137,"Reference 26 - ""Guidance for Industry: Biological Product Deviation Reporting for Blood and Plasma Establishments, October 2006"" - [re FDA-2009-D-0137-0002]",Supporting & Related Material,REF-Reference (internal unless indicated),2009-03-30T04:00:00Z,2009,3,,,2011-06-29T19:45:14Z,,0,0,090000648092ff42
FDA-2009-D-0137-0010,FDA,FDA-2009-D-0137,"Reference 29 - ""FDA Blood Products Advisory Committee Meeting, September 12, 2002"" - [re FDA-2009-D-0137-0002]",Supporting & Related Material,REF-Reference (internal unless indicated),2009-03-30T04:00:00Z,2009,3,,,2011-06-29T19:49:33Z,,0,0,090000648092ffba
FDA-2009-D-0137-0006,FDA,FDA-2009-D-0137,"Reference 15 -  CDC/MMWR , ""Chagas Disease After Organ Transplantation - Los Angeles, California, 2006"" - [re FDA-2009-D-0137-0002]",Supporting & Related Material,REF-Reference (internal unless indicated),2009-03-30T04:00:00Z,2009,3,,,2011-06-29T19:37:58Z,,0,0,090000648092fd18
FDA-2009-D-0137-0005,FDA,FDA-2009-D-0137,"Reference 14 - CDC/MMWR , ""Chagas Disease After Organ Transplantation - United States, 2001"" - [re FDA-2009-D-0137-0002]",Supporting & Related Material,REF-Reference (internal unless indicated),2009-03-30T04:00:00Z,2009,3,,,2011-06-29T19:35:35Z,,0,0,090000648092fd07
FDA-2009-D-0137-0007,FDA,FDA-2009-D-0137,"Reference 24 - CDC/MMWR, ""Blood Donor Screening for Chagas Disease - United States, 2006-2007"" - [re FDA-2009-D-0137-0002]",Supporting & Related Material,REF-Reference (internal unless indicated),2009-03-30T04:00:00Z,2009,3,,,2011-06-29T19:39:42Z,,0,0,090000648092ff2c
FDA-2009-D-0137-0008,FDA,FDA-2009-D-0137,"Reference 25 - ""FDA Blood Products Advisory Committee, 89th Meeting, April 27, 2007 (Concept Paper)"" - [re FDA-2009-D-0137-0002]",Supporting & Related Material,REF-Reference (internal unless indicated),2009-03-30T04:00:00Z,2009,3,,,2011-06-29T19:43:30Z,,0,0,090000648092ff3a
FDA-2009-D-0137-0004,FDA,FDA-2009-D-0137,"Reference 1 - ""Guidance for Industry: Eligibility Determination for Donors of Human Cells, Tissues, and Cellular and Tissue-Based Products (HCT/Ps), August 2007"" - [re FDA-2009-D-0137-0002]",Supporting & Related Material,REF-Reference (internal unless indicated),2009-03-29T04:00:00Z,2009,3,,,2011-06-29T19:14:36Z,,0,0,090000648092fa11
FDA-2009-D-0137-0002,FDA,FDA-2009-D-0137,"Guidance for Industry - Use of Serological Tests to Reduce the Risk of Transmission of Trypanosoma cruzi Infection in Whole Blood and Blood Components for Transfusion and Human Cells, Tissues, and Cellular and Tissue-Based Products (HCT/Ps) - Guidance",Other,Guidance,2009-03-26T04:00:00Z,2009,3,2009-03-26T04:00:00Z,,2011-06-29T17:49:54Z,,0,0,0900006480930814
FDA-2009-D-0137-0003,FDA,FDA-2009-D-0137,Table of Contents - References [re FDA-2009-D-0137-0002],Supporting & Related Material,REF-Reference (internal unless indicated),2009-03-26T04:00:00Z,2009,3,,,2011-06-29T19:10:28Z,,0,0,0900006480931787
FDA-2009-D-0137-0001,FDA,FDA-2009-D-0137,"Draft Guidance for Industry: Use of Serological Tests to Reduce the Risk of Transmission of Trypanosoma cruzi Infection in Whole Blood and Blood Components for Transfusion and Human Cells, Tissues, and Cellular and Tissue-Based Products",Notice,NAD-Notice of Availability of Data,2009-03-26T04:00:00Z,2009,3,2009-03-26T04:00:00Z,2009-06-25T03:59:59Z,2011-06-29T17:38:37Z,E9-06684,0,0,0900006480930640